✦ LIBER ✦

Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro

✍ Scribed by Gerda Partik; Karin Hochegger; Michaela Schörkhuber; Brigitte Marian

Publisher: Springer-Verlag
Year: 1999
Tongue: English
Weight: 254 KB
Volume: 125
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s004320050290

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A potent protein-tyrosine kinase inhibit

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo

✍ Nicholas B. Lydon; Helmut Mett; Marcel Mueller; Michael Becker; Robert M. Cozens 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB 👁 2 views

Cytotoxic effects induced by a combinati

Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells

✍ Murielle Mimeault; Erik Moore; Nicolas Moniaux; Jean-Pierre Hénichart; Patrick D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 552 KB

## Abstract Although the blockade of the hedgehog cascade by using cyclopamine has been reported to inhibit the growth of some cancer cell types, few studies on the mechanism by which this drug alone or in combination with other cytotoxic agents induces its cytotoxic effect have been reported. In o

Targeted inhibition of the epidermal gro

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 (‘Iressa’) induces cell-cycle arrest and inhibits proliferation in prostate cancer cells

✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (‘Iressa’), an orally a

A potent protein-tyrosine kinase inhibit

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo. Int. J. Cancer,76, 154–163 (1998)

✍ N. Lydon; H. Mett; M. Mueller; M. Becker; R.M. Cozens; D. Daniels; P. Traxler; E 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 8 KB 👁 2 views

Downregulation of the antiapoptotic MCL-

Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor–Pseudomonas exotoxin a immunotoxin

✍ Yvonne Andersson; Siri Juell; Øystein Fodstad 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 582 KB

## Abstract __Pseudomonas__ exotoxin (PE)–containing immunotoxins (ITs) act by arresting protein synthesis and promoting apoptosis, but the mechanisms of the induced apoptosis and the relationship to protein synthesis inhibition is not well elucidated. We studied these effects in MA‐11 human breast

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant